SightfileU.S. market data from official filings

Companies › IGC

IGC PHARMA INC (IGC)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001326205 · EDGAR filings · Updated 2026-07-14

IGC PHARMA INC (IGC) has reported institutional ownership of 4.4%, with 35 institutional managers holding positions valued at $1.14M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
4.4%
Institutional managers
35
Reported 13F value
$1.14M
Insider activity
14 trans.
$0 net flat
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IGC PHARMA INC has 35 institutional holders and institutional ownership of 4.4%.

Insider activity

Insiders reported 14 transactions (0 buys, 0 sells) across 4 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2023-07-07) — source filing. The authoritative details are those stated in the filing itself.

Related companies

BiomX Inc (PHGE) · PULSENMORE LTD (PLSM) · Lexaria Bioscience Corp (LEXX) · Alterity Therapeutics Ltd (ATHE) · VSee Health Inc (VSEE) · Mannatech Inc (MTEX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-14.